Inventor
ERLANDER MARK
US11 patents
⚠️ This page may combine multiple inventors who share the name “ERLANDER MARK”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ORTHO PHARMA CORP
3 patentsUS6136559AOct 24, 2000
DNA encoding as human histamine receptor of the H3 subtype
ORTHO PHARMA CORP28 citations94
US6437100B1Aug 20, 2002
DNA encoding a human histamine receptor of the H3 subtype
ORTHO PHARMA CORP4 citations72
US6413743B1Jul 2, 2002
DNA encoding a human histamine receptor of the H3 subtype
ORTHO PHARMA CORP4 citations72
ORTHO MCNEIL PHARM INC
3 patentsUS6855560B1Feb 15, 2005
Method of identifying compounds that modulate human histamine H3 receptor
ORTHO MCNEIL PHARM INC7 citations72
US7179604B2Feb 20, 2007
Methods of use of DNA encoding a human histamine receptor of the H3 subtype
ORTHO MCNEIL PHARM INC1 citations61
US7049401B1May 23, 2006
Human histamine receptor of the H3 subtype
ORTHO MCNEIL PHARM INC0 citations51
CARDIFF ONCOLOGY INC
3 patentsUS12263173B2Apr 1, 2025
PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
CARDIFF ONCOLOGY INC0 citations53
US12144813B2Nov 19, 2024
PLK1 inhibitor in combination with anti-angiogenics for treating metastatic cancer
CARDIFF ONCOLOGY INC0 citations53
US11957677B2Apr 16, 2024
Cancer treatment using FGFR inhibitors and PLK1 inhibitors
CARDIFF ONCOLOGY INC0 citations48